OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,140 | -86.7% | 1,000 | -78.2% | 0.00% | – |
Q2 2023 | $23,664 | -25.2% | 4,586 | -23.6% | 0.00% | -100.0% |
Q1 2023 | $31,620 | +22.0% | 6,000 | -35.0% | 0.00% | – |
Q4 2022 | $25,922 | +8.0% | 9,225 | +61.1% | 0.00% | – |
Q3 2022 | $24,000 | +242.9% | 5,725 | +231.9% | 0.00% | – |
Q2 2022 | $7,000 | -22.2% | 1,725 | 0.0% | 0.00% | – |
Q1 2022 | $9,000 | -25.0% | 1,725 | 0.0% | 0.00% | – |
Q4 2021 | $12,000 | -29.4% | 1,725 | 0.0% | 0.00% | – |
Q3 2021 | $17,000 | -29.2% | 1,725 | 0.0% | 0.00% | – |
Q2 2021 | $24,000 | -100.0% | 1,725 | -50.0% | 0.00% | – |
Q1 2021 | $56,614,000 | +157161.1% | 3,450 | +100.0% | 0.00% | -100.0% |
Q4 2020 | $36,000 | +260.0% | 1,725 | +25.5% | 0.00% | – |
Q3 2020 | $10,000 | +25.0% | 1,375 | +37.5% | 0.00% | – |
Q2 2020 | $8,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |